vimarsana.com

Investment analysts at StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a report released on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded shares of Onconova Therapeutics from a “neutral” rating to a “buy” rating and set a $11.00 price target on […]

Related Keywords

E Premkumar Reddy ,Ramesh Kumar ,Onconova Therapeutics Inc ,Beacon Pointe Advisors ,Vanguard Group Inc ,Renaissance Technologies ,Millennium Management ,Onconova Therapeutics ,Get Rating ,Pointe Advisors ,Vanguard Group ,Onconova Therapeutics Daily ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.